Supplemented Infant Formula and Human Breast Milk Show Similar Patterns in Modulating Infant Microbiota Composition and Function In Vitro

Klaudyna Borewicz,Wolfram Manuel Brück

DOI: https://doi.org/10.3390/ijms25031806

IF: 5.6

2024-02-03

International Journal of Molecular Sciences

Abstract:The gut microbiota of healthy breastfed infants is often dominated by bifidobacteria. In an effort to mimic the microbiota of breastfed infants, modern formulas are fortified with bioactive and bifidogenic ingredients. These ingredients promote the optimal health and development of infants as well as the development of the infant microbiota. Here, we used INFOGEST and an in vitro batch fermentation model to investigate the gut health-promoting effects of a commercial infant formula supplemented with a blend containing docosahexaenoic acid (DHA) (20 mg/100 kcal), polydextrose and galactooligosaccharides (PDX/GOS) (4 g/L, 1:1 ratio), milk fat globule membrane (MFGM) (5 g/L), lactoferrin (0.6 g/L), and Bifidobacterium animalis subsp. lactis, BB-12 (BB-12) (106 CFU/g). Using fecal inoculates from three healthy infants, we assessed microbiota changes, the bifidogenic effect, and the short-chain fatty acid (SCFA) production of the supplemented test formula and compared those with data obtained from an unsupplemented base formula and from the breast milk control. Our results show that even after INFOGEST digestion of the formula, the supplemented formula can still maintain its bioactivity and modulate infants' microbiota composition, promote faster bifidobacterial growth, and stimulate production of SCFAs. Thus, it may be concluded that the test formula containing a bioactive blend promotes infant gut microbiota and SCFA profile to something similar, but not identical to those of breastfed infants.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the regulatory effect of a commercial infant formula (supplemented with specific bioactive components) on the composition and function of the infant gut microbiota in vitro experiments, and compare it with breast milk to verify whether this formula can mimic the effect of breast milk in promoting infant gut health. Specifically, the researchers hope to evaluate the following points through this experiment:

1. **Changes in the microbial community**: Observe whether the infant formula supplemented with specific bioactive components can maintain its bioactivity after digestion and whether it can regulate the composition of the infant's gut microbiota, especially promote the growth of bifidobacteria.
2. **Production of short - chain fatty acids (SCFA)**: Evaluate whether this formula can stimulate the production of SCFA, which is an important indicator of gut health.
3. **Comparison with breast milk**: Evaluate the effect of this formula supplemented with bioactive components by comparing it with breast milk and the basic formula without bioactive components.

The research background emphasizes that breast milk is the optimal nutritional source for infant health. In particular, the non - nutritive bioactive factors in breast milk play an important role in the development of the infant's immune, endocrine and nervous systems. Therefore, modern infant formulas are often supplemented with various functional components, such as prebiotics, polyunsaturated fatty acids (such as DHA), lactoferrin, etc., to better mimic the health - promoting functions of breast milk.

Through this research, the author hopes to provide a scientific basis for improving existing commercial infant formulas, making them an effective substitute for breast milk, especially in cases where breastfeeding is not feasible.